Pharmaceutical Preparations · DE · CIK 1517022
Develops and commercializes innovative therapeutics for patients impacted by kidney disease
Comparable business profile · signals at a glance
In the 90 days to Mar 4, 2026: 1 insider bought $87K · 6 sold $901K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | Butler John P.CEO and President | Buy | 69,270 | $1.25 | $87K |
| Feb 2, 2026 | Butler John P.CEO and President | Sell | 114,891 | $1.39 | $160K |
| Feb 2, 2026 | Butler John P.CEO and President | Sell | 96,065 | $1.39 | $134K |
| Feb 2, 2026 | Butler John P.CEO and President | Sell | 83,689 | $1.39 | $116K |
| Feb 2, 2026 | Grund NicholasChief Commercial Officer | Sell | 53,585 | $1.39 | $74K |
| Feb 2, 2026 | Butler John P.CEO and President | Sell | 46,660 | $1.39 | $65K |
| Feb 2, 2026 | Malabre Richard CSVP, Chief Accounting Officer | Sell | 36,142 | $1.39 | $50K |
| Feb 2, 2026 | Ostrowski ErikSVP, CFO, CBO & Treasurer | Sell | 34,951 | $1.39 | $49K |
| Feb 2, 2026 | Grund NicholasChief Commercial Officer | Sell | 31,244 | $1.39 | $43K |
| Feb 2, 2026 | Rucci Carolyn M.SVP, Chief Legal Officer | Sell | 27,544 | $1.39 | $38K |
| Feb 2, 2026 | Rucci Carolyn M.SVP, Chief Legal Officer | Sell | 25,382 | $1.39 | $35K |
| Feb 2, 2026 | Burke Steven KeithSVP, Chief Medical Officer | Sell | 25,375 | $1.39 | $35K |
| Feb 2, 2026 | Burke Steven KeithSVP, Chief Medical Officer | Sell | 21,582 | $1.39 | $30K |
| Feb 2, 2026 | Burke Steven KeithSVP, Chief Medical Officer | Sell | 20,701 | $1.39 | $29K |
| Feb 2, 2026 | Rucci Carolyn M.SVP, Chief Legal Officer | Sell | 16,846 | $1.39 | $23K |
| Feb 2, 2026 | Malabre Richard CSVP, Chief Accounting Officer | Sell | 13,382 | $1.39 | $19K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.